| Morgan Hensler, AUD | |
|
4230 Wornall Road, Suite 420, Kansas City, MO 64111 | |
| (816) 932-1660 | |
| (816) 932-1675 |
| Full Name | Morgan Hensler |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 4230 Wornall Road, Kansas City, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730595026 | NPI | - | NPPES |
| 2014021750 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 2014021750 (Missouri) | Primary |
| Provider Name | St Lukes Hospital Of Kansas City |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1063494177 PECOS PAC ID: 9436060084 Enrollment ID: O20031112000506 |
News Archive
Boston Scientific Corporation today announced the settlement of three patent disputes with Johnson & Johnson (J&J). The disputes date back to 2003 and cover Boston Scientific's Jang patent and J&J's Palmaz and Gray patents, all of which involve intellectual property in the cardiovascular arena. Boston Scientific will make a $1.725 billion payment to J&J in connection with the settlement.
A study in the March 2009 issue of Anesthesiology found that, in neurosurgical patients receiving postoperative intensive care, intensive insulin therapy - compared to conventional insulin therapy - leads to conflicting results: It increases the risk of hypoglycemic episodes, but reduces the incidence of postoperative infections and the length of stay in the intensive care unit.
Serametrix Corporation has announced the launch of an important new blood test for cancer patients. The test measures a patient's level of circulating Myeloid Derived Suppressor Cells (MDSCs) that are known to decrease anti-tumor immunity and are associated with poor survival rates in cancer patients.
The heart has its own dedicated blood supply, with coronary arteries that supply oxygen-rich blood to the heart and cardiac veins that remove deoxygenated blood. This system of vessels nourishes the heart, enabling it to pump blood to all the other organs and tissues of the body. Yet despite their critical importance, the process and molecules required for coronary vessel development have not been fully determined.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Morgan Hensler, AUD 4320 Wornall Road, Suite 420, Kansas City, MO 64111 Ph: (816) 932-1660 | Morgan Hensler, AUD 4230 Wornall Road, Suite 420, Kansas City, MO 64111 Ph: (816) 932-1660 |
News Archive
Boston Scientific Corporation today announced the settlement of three patent disputes with Johnson & Johnson (J&J). The disputes date back to 2003 and cover Boston Scientific's Jang patent and J&J's Palmaz and Gray patents, all of which involve intellectual property in the cardiovascular arena. Boston Scientific will make a $1.725 billion payment to J&J in connection with the settlement.
A study in the March 2009 issue of Anesthesiology found that, in neurosurgical patients receiving postoperative intensive care, intensive insulin therapy - compared to conventional insulin therapy - leads to conflicting results: It increases the risk of hypoglycemic episodes, but reduces the incidence of postoperative infections and the length of stay in the intensive care unit.
Serametrix Corporation has announced the launch of an important new blood test for cancer patients. The test measures a patient's level of circulating Myeloid Derived Suppressor Cells (MDSCs) that are known to decrease anti-tumor immunity and are associated with poor survival rates in cancer patients.
The heart has its own dedicated blood supply, with coronary arteries that supply oxygen-rich blood to the heart and cardiac veins that remove deoxygenated blood. This system of vessels nourishes the heart, enabling it to pump blood to all the other organs and tissues of the body. Yet despite their critical importance, the process and molecules required for coronary vessel development have not been fully determined.
› Verified 6 days ago
Michelle Renee Middleton, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Hearing And Speech Clinic, Kansas City, MO 64108 Phone: 816-960-4009 | |
Ann D Hatfield, MA Audiologist Medicare: Medicare Enrolled Practice Location: 4320 Wornall Rd Ste 420, Kansas City, MO 64111 Phone: 816-932-1660 | |
Kristin L Lisbona, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4801 E Linwood Blvd, Kansas City, MO 64128 Phone: 816-861-4700 | |
Hilary Turner Schmidt, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3677 | |
Adela J Bortone, MA,CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 4320 Wornall Rd, 512, Kansas City, MO 64111 Phone: 816-753-5663 | |
Dr. Stephan Lee Mccall, PH.D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4801 E Linwood Blvd, Audiology, Kansas City, MO 64128 Phone: 816-861-4700 | |
Mrs. Joey Coleman Ford, M.S., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3764 Fax: 816-234-3291 |